438 related articles for article (PubMed ID: 3157587)
1. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
[TBL] [Abstract][Full Text] [Related]
2. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
MacKenzie RG; Zigmond MJ
J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330
[TBL] [Abstract][Full Text] [Related]
3. Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates.
de Vries DJ; Beart PM
Brain Res; 1986 Jul; 387(1):29-35. PubMed ID: 3742232
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
5. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
George SR; Watanabe M; Seeman P
J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
[TBL] [Abstract][Full Text] [Related]
7. Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors.
Lévesque D; Di Paolo T
Biochem Pharmacol; 1993 Feb; 45(3):723-33. PubMed ID: 8095140
[TBL] [Abstract][Full Text] [Related]
8. Vanadate inhibits agonist binding to D2 dopamine receptor.
Elazar Z; Fuchs S
J Mol Neurosci; 1991; 3(1):1-6. PubMed ID: 1679343
[TBL] [Abstract][Full Text] [Related]
9. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
Fuxe K; Agnati LF; Köhler C; Kuonen D; Ogren SO; Andersson K; Hökfelt T
J Neural Transm; 1981; 51(1-2):3-37. PubMed ID: 7264628
[TBL] [Abstract][Full Text] [Related]
10. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
Geurts M; Hermans E; Maloteaux JM
Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146
[TBL] [Abstract][Full Text] [Related]
11. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
12. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
Tecott LH; Kwong LL; Uhr S; Peroutka SJ
Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
[TBL] [Abstract][Full Text] [Related]
14. Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
Norman AB; Battaglia G; Creese I
J Neurosci; 1987 May; 7(5):1484-91. PubMed ID: 2952771
[TBL] [Abstract][Full Text] [Related]
15. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
[TBL] [Abstract][Full Text] [Related]
16. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
18. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
[TBL] [Abstract][Full Text] [Related]
19. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
Gundlach AL; Krstich M; Beart PM
Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
